Pfizer opens enrollment for Rx program

22 August 2004

Pfizer announced August 19 that all uninsured people in America,regardless of age or income, can start saving on their Pfizer medicines by calling the Pfizer Helpful Answers toll-free number: 1-866-706-2400 or accessing the web site: www.pfizerhelpfulanswers.com.

"Anyone who needs a Pfizer medicine and does not have insurance covering prescriptions should take advantage of Helpful Answers," said Pfizer chief executive Hank McKinnell.

Helpful Answers provides one-stop-shopping to help uninsured people identify and enroll in the Pfizer program that is best for them, including existing patient assistance initiatives and the new Pfizer Pfriends program, announced July 7, 2004. It will also refer patients to other programs for which they may be eligible, such as Medicaid, state prescription assistance programs and other publicly-funded programs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight